Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Lastest Finance News

IN BRIEF: EPE Special Opportunities plans GBP3 million share buyback

13th Feb 2026 10:58

EPE Special Opportunities Ltd - investment company managed by Epic Investment Partners LLP that aims to provide long-term return on equity by investing between GBP2 million and GBP30 million in small and medium sized companies - Sets out plan for up to GBP3.0 million in share buybacks, funded from its cash reserves. The buyback will be run by Deutsche Bank AG London Branch, trading as Deutsche Numis, and repurchased shares will be held in treasury. EPE Special Situations notes that the low market liquidity of its shares means that its buybacks may exceed 25% of average daily trading volume on any given day. Read More

IN BRIEF: Magnum Ice Cream directors buy EUR1.3 million in shares

13th Feb 2026 10:56

Magnum Ice Cream Co NV - Amsterdam-based ice cream company spun off from Unilever PLC and owner of Magnum, Ben & Jerry's and Cornetto brands - Chief Financial Officer Abhijit Bhattacharya buys 44,500 shares on Thursday at EUR14.04 each, a total of EUR624,609. Chief of Staff Tim Gunning buys 6,000 shares at EUR14.00 each, a total of EUR84,000. Gerardo Rozanski, president of the Americas region, buys 20,000 shares between EUR16.02 and EUR16.08 each for a total of EUR321,000. Mustafa Seckin, president of the Europe and Australia & New Zealand, buys 13,960 shares between EUR14.20 and EUR14.50 each for a total of EUR199,266. Chief Legal Officer Vanessa Vilar buys 3,521 shares for EUR14.20 each for a total of EUR49,998. Non-Executive Director Stefan Bomhard buys 3,000 shares for EUR14.05 each for a total of EUR41,250. Read More

AIM WINNERS & LOSERS: SkinBioTherapeutics sinks as CEO suspended

13th Feb 2026 10:34

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday. Read More

Safran hails booming defence business in "record" annual results

13th Feb 2026 10:15

(Alliance News) - Safran SA on Friday pointed to a rise in defence business as it posted "record" annual results and outlined medium-term financial targets. Read More

European Opportunities Trust starts review; River Global offers exit

13th Feb 2026 10:14

(Alliance News) - European Opportunities Trust PLC on Friday said it has started a strategic review of its future, warning it is unlikely to meet the conditions for its performance-related tender offer later this year. Read More

SMALL-CAP WINNERS & LOSERS: Contango jumps on GBP5 million raise

13th Feb 2026 10:12

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday. Read More

LONDON BROKER RATINGS: Bernstein, Barclays and Deutsche lower Relx

13th Feb 2026 09:51

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

NatWest surpasses forecasts as full-year profit climbs 24%

13th Feb 2026 09:31

(Alliance News) - NatWest Group PLC on Friday reported improved full-year and fourth-quarter earnings, with its total dividend rising by 51% and a timeline outlined for its GBP750 million buyback scheme. Read More

LONDON MARKET OPEN: Shares steady after global AI-led sell-off

13th Feb 2026 09:22

(Alliance News) - Stock prices in London opened slightly higher on Friday, as markets steadied following a sharp US and Asian sell-off sparked by renewed artificial intelligence fears, while investors digested fresh economic signals from Europe and awaited US inflation data. Read More

GCP Infrastructure Investments posts dip in net asset value per share

13th Feb 2026 09:19

(Alliance News) - GCP Infrastructure Investments Ltd on Friday said it continued to progress disposals as it announced a slight decline in net asset value per share. Read More

AstraZeneca rises on positive trial results for asthma therapy

13th Feb 2026 09:16

(Alliance News) - Astrazeneca on Friday hailed positive results from a phase-three trial of its asthma treatment breztri aerosphere. Read More

IN BRIEF: SkinBioTherapeutics CEO Ashman resigns amid probe of conduct

13th Feb 2026 08:53

SkinBioTherapeutics PLC - Newcastle Upon Tyne, England-based life science firm focused on skin health - Chief Executive Officer Stuart Ashman resigns after being suspended by the board "pending an investigation into matters relating to his conduct". SkinBioTherapeutics provides "no further comment" on the subject of the probe, saying it is "undertaking a full investigation, supported by its professional advisors". Non-Executive Chair Martin Hunt becomes executive chair temporarily while the company looks for an interim CEO and then new permanent CEO. Back in October, Chief Operating Officer Simon Hewitson had left, with his duties taken over by Ashman and Finance Director Emily Bertram. Read More

LONDON BRIEFING: NatWest results ahead of forecasts, ups dividend 51%

13th Feb 2026 07:58

(Alliance News) - NatWest beats annual earnings expectations and boosts shareholder returns, while AstraZeneca reports positive late-stage trial data for Breztri in asthma, as UK retail footfall improves from a weak Christmas period but remains below last year's levels. Read More

IN BRIEF: Delta Gold announces new sponsorship deal with Penn State

13th Feb 2026 07:01

Delta Gold Technologies PLC - developing intellectual property aimed at the quantum computing space that can be licensed globally - Announces research sponsorship and exclusive technology licensing agreement with Penn State University in Pennsylvania, US. Delta will sponsor a first year research programme estimated to be up to USD997,142 which will be paid to Penn State on a cost reimbursement basis. "The research will extend existing work on gold-based quantum technologies with the aim of generating valuable intellectual property," Delta says. The total cost reimbursable contract is for up to around USD3.0 million over three years. Read More

LONDON MARKET EARLY CALL: FTSE 100 seen higher following US sell-off

13th Feb 2026 06:59

(Alliance News) - Stocks in London are set to open higher on Friday, ahead of US consumer price inflation data and following an across-the-board sell-off on Wall Street and in Asian markets. Read More

12345678910
FTSE 100 Latest
Value10,407.82
Change5.38